In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

In the UK, most prostate cancers are diagnosed in men aged 75–79, but rates rise steeply from 45–49. Black men are also more ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

This “watch-and-wait” approach is recommended for all prostate cancer patients who will likely die of some other cause, ...

In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

When prostate cancer cells burst as a result of menadione treatment, there is no risk of metastasis ... However, the study ...